Alpheus Medical - About the company
Alpheus Medical is a series B company based in Chanhassen (United States), founded in 2014 by Vijay Agarwal. It operates as a Developer of Sonodynamic therapy device for brain cancer. Alpheus Medical has raised $76.5M in funding from investors like Orbimed, Health Quest Capital and Action Potential Venture Capital. The company has 79 active competitors, including 21 funded and 12 that have exited. Its top competitors include companies like Alpha Tau Medical, RefleXion and Elekta.
Company Details
Developer of Sonodynamic therapy device for brain cancer. It offers a proprietary non-invasive treatment device that utilizes ultrasound to activate a drug targeting cancer cells for outpatient treatment of recurrent glioblastoma multiforme and selectively target and kill cancer cells.
- Website
- alpheusmedical.com
- Email ID
- *****@alpheusmedical.com
Key Metrics
Founded Year
2014
Location
Chanhassen, United States
Stage
Series B
Total Funding
$76.5M in 2 rounds
Latest Funding Round
Ranked
8th among 79 active competitors
Employee Count
12 as on Sep 30, 2026
Similar Companies
Sign up to download Alpheus Medical's company profile
Alpheus Medical's funding and investors
Alpheus Medical has raised a total funding of $76.5M over 2 rounds. Its first funding round was on Nov 17, 2021. Its latest funding round was a Series B round on May 02, 2025 for $*****. 7 investors participated in its latest round. Alpheus Medical has 9 institutional investors.
Here is the list of recent funding rounds of Alpheus Medical:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 02, 2025 | 4794299 | Series B | 6413061 | 6301973 | 1909835 | 3793556 |
Nov 17, 2021 | 3335019 | Series A | 9291076 | 5416487 |
View details of Alpheus Medical's funding rounds and investors
Alpheus Medical's founders and board of directors
Founder? Claim ProfileThe founders of Alpheus Medical is Vijay Agarwal. Vijay Agarwal is the CEO of Alpheus Medical.
Here are the details of Alpheus Medical's key team members:
- Vijay Agarwal: Founder & CEO of Alpheus Medical. Contact Info: 1 email address
View details of Alpheus Medical's Founder profiles and Board Members
Alpheus Medical's employee count trend
Alpheus Medical has 12 employees as of Sep 26. Here is Alpheus Medical's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Alpheus Medical's Competitors and alternates
Top competitors of Alpheus Medical include Alpha Tau Medical, RefleXion and Elekta. Here is the list of Top 10 competitors of Alpheus Medical, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Alpha Tau Medical 2015, Tel Aviv (Israel), Public | Developer of radiotherapy technique for the treatment of solid cancer tumors | $55M | 68/100 | |
2nd | RefleXion 2009, Hayward (United States), Series F | Provider of biology-guided radiotherapy system | $542M | 66/100 | |
3rd | Manufacturer of radiation therapy systems and cancer treatment technology equipment | - | 61/100 | ||
4th | Vergent Biosciences 2014, Minneapolis (United States), Series B | Developing tumor-targeted imaging agents for improved cancer surgery outcomes | $57M | 61/100 | |
5th | ABK Biomedical 2012, Halifax (Canada), Series D | Developer of imageable embolic medical devices targeting benign and malignant hypervascular tumors | $140M | 61/100 | |
6th | Mevion Medical Systems 2004, Littleton (United States), Series F | Proton therapy systems for oncology | $500M | 62/100 | |
7th | ZAP-X 2014, San Carlos (United States), Series E | Developer of gyroscopic radiosurgery platform | $160M | 59/100 | |
8th | Alpheus Medical 2014, Chanhassen (United States), Series B | Developer of Sonodynamic therapy device for brain cancer | $76.5M | 58/100 | |
9th | Cel-Sci 1983, Vienna (United States), Public | Developer of immunotherapy products for the treatment of cancer and infectious diseases | - | 53/100 | |
10th | AI-powered radiation therapy platform for cancer treatment | $4.88M | 49/100 |
Looking for more details on Alpheus Medical's competitors? Click here to see the top ones
Alpheus Medical's Investments and acquisitions
Alpheus Medical has made no investments or acquisitions yet.
Reports related to Alpheus Medical
Here is the latest report on Alpheus Medical's sector:
News related to Alpheus Medical
Media has covered Alpheus Medical for 1 event in last 1 year.
•
Alpheus Medical Initiates Phase 2b Trial of Investigational Therapy for Newly Diagnosed GlioblastomaPR Newswire•Apr 09, 2026•Alpheus Medical
•
Alpheus Medical Secures $52M in Series B Funding for Glioblastoma Therapyintelligence360•May 22, 2025•Alpheus Medical, Health Quest Capital, Sprig Consulting
•
Alpheus Medical Secures $52M in Series B FundingFinSMEs•May 15, 2025•Alpheus Medical, Health Quest Capital, Orbimed, Action Potential Venture Capital and 3 others
•
Early tests show promise for sonodynamic therapy in treating new glioblastomas.PR Newswire•Feb 25, 2025•Alpheus Medical
•
Alpheus Medical Announces Positive Phase 1/2 Trial Results for the Treatment of Recurrent High-Grade GliomasPR Newswire•Nov 24, 2024•Alpheus Medical
•
Alpheus Medical Announces Positive Phase 1/2 Trial Results for the Treatment of Recurrent High-Grade GliomasAlpheus Medical•Jan 24, 2024•Alpheus Medical
•
Alpheus Medical Treats First Patients in First-In-Human Clinical Trial for Novel High-Grade Glioma Brain Cancer TreatmentAlpheus Medical•Oct 11, 2022•Alpheus Medical
•
FDA Grants Alpheus Medical Orphan Drug and Fast Track Designations for Novel Sonodynamic Therapy for Brain CancerAlpheus Medical•Jul 13, 2022•Alpheus Medical
•
FDA Grants Alpheus Medical Orphan Drug and Fast Track Designations for Novel Sonodynamic Therapy for Brain CancerPR Newswire•Jul 13, 2022•Alpheus Medical
•
Alpheus Medical Announces Formation of World-Class Scientific Advisory Board (SAB) to Support Development of Novel Treatment for Brain CancerAlpheus Medical•Feb 03, 2022•Alpheus Medical
Are you a Founder ?
FAQs about Alpheus Medical
Explore our recently published companies
- Deva Dhare - Unfunded company
- DP Home - Southampton based, Unfunded company
- Polskie ePatnosci - Unfunded company
- Celebritygist - 2024 founded, Unfunded company
- Hype Program - United Kingdom based, Unfunded company
- Keyzone Properties - United Kingdom based, Unfunded company
